Paper1494073
Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity.
Ginsberg GM and 1 other. J Epidemiol Community Health, 1992. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity. Papers, record 1494073. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1494073
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B | Major topic |
| Hepatitis B Vaccines | Major topic |
| Immunization | Major topic |
| Cost-Benefit Analysis | |
| Humans | |
| Incidence | |
| Infant, Newborn | |
| Israel |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3723115 | Perinatal transmission of hepatitis B virus in Kenya: its relation to the presence of serum HBV-DNA and anti-HBe in the mother. | J Med Virol | 1986 | https://conductscience.org/library/papers/3723115 | PubMed |
| 2 | 3192122 | [Infectious disease morbidity in Kibbutzim]. | Harefuah | 1988 | https://conductscience.org/library/papers/3192122 | PubMed |
| 3 | 4118686 | Natural history of hepatitis-associated antigen-positive chronic liver disease. | Lancet | 1972 | https://conductscience.org/library/papers/4118686 | PubMed |
| 4 | 4153785 | Posthepatitis syndromes. | Clin Gastroenterol | 1974 | https://conductscience.org/library/papers/4153785 | PubMed |
| 5 | 4315927 | Viral hepatitis in Israel: morbidity and mortality data. | Am J Epidemiol | 1970 | https://conductscience.org/library/papers/4315927 | PubMed |
| 6 | 4608655 | Chronic viral hepatitis. | Clin Gastroenterol | 1974 | https://conductscience.org/library/papers/4608655 | PubMed |
| 7 | 6109938 | Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal). | Lancet | 1981 | https://conductscience.org/library/papers/6109938 | PubMed |
| 8 | 6118576 | Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. | Lancet | 1981 | https://conductscience.org/library/papers/6118576 | PubMed |
| 9 | 6126411 | Viral hepatitis during pregnancy in Israel. | Int J Gynaecol Obstet | 1982 | https://conductscience.org/library/papers/6126411 | PubMed |
| 10 | 6138642 | Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. | Lancet | 1983 | https://conductscience.org/library/papers/6138642 | PubMed |
| 11 | 6229201 | Hepatitis B vaccine. Health and Public Policy Committee, American College of Physicians. | Ann Intern Med | 1984 | https://conductscience.org/library/papers/6229201 | PubMed |
| 12 | 6262862 | Hepatitis B infection and primary liver cancer. | Prog Med Virol | 1981 | https://conductscience.org/library/papers/6262862 | PubMed |
| 13 | 6264023 | Hepatitis A antibody in Israel Defence Forces recruits. | J Med Virol | 1981 | https://conductscience.org/library/papers/6264023 | PubMed |
| 14 | 6277763 | Primary hepatocellular carcinoma--etiology, pathogenesis, and prevention. | Hum Pathol | 1981 | https://conductscience.org/library/papers/6277763 | PubMed |
| 15 | 6293033 | Persistent infection of humans with hepatitis B virus: mechanisms and consequences. | Rev Infect Dis | 1982 | https://conductscience.org/library/papers/6293033 | PubMed |
| 16 | 6339349 | Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. | Hepatology | 1983 | https://conductscience.org/library/papers/6339349 | PubMed |
| 17 | 6405916 | Should homosexuals be vaccinated against hepatitis B virus? Cost and benefit assessment. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6405916 | PubMed |
| 18 | 6434124 | Indications for hepatitis B immunoglobulin for neonates of HBsAg carrier mothers. | Br Med J (Clin Res Ed) | 1984 | https://conductscience.org/library/papers/6434124 | PubMed |
| 19 | 6747609 | Detection and characterization of hepatitis B virus DNA in serum of HBe antigen-negative HBsAg carriers. | J Med Virol | 1984 | https://conductscience.org/library/papers/6747609 | PubMed |
| 20 | 6805749 | Acute viral hepatitis B: laboratory reports 1975-9. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6805749 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39591157 | Hepatitis B Virus-Related Cirrhosis and Hepatocellular Carcinoma Hospital Discharge Rates from 2005 to 2021 in Spain: Impact of Universal Vaccination. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39591157 | PubMed |
| 35632549 | The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/35632549 | PubMed |
| 31656166 | Clinical practice guideline management of blood borne viruses within the haemodialysis unit. | BMC Nephrol | 2019 | https://conductscience.org/library/papers/31656166 | PubMed |
| 25132754 | Hepatitis B vaccine by intradermal route in non responder patients: an update. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/25132754 | PubMed |
| 23326280 | Hepatitis B vaccination in chronic kidney disease: review of evidence in non-dialyzed patients. | Hepat Mon | 2012 | https://conductscience.org/library/papers/23326280 | PubMed |
| 22077578 | Cost-effectiveness analysis of prophylactic lamivudine use in preventing vertical transmission of hepatitis B virus infection. | Pharmacoeconomics | 2011 | https://conductscience.org/library/papers/22077578 | PubMed |
| 10174324 | Cost-benefit analysis of riluzole for the treatment of amyotrophic lateral sclerosis. | Pharmacoeconomics | 1997 | https://conductscience.org/library/papers/10174324 | PubMed |
| 10155330 | Cost-effectiveness analysis of hepatitis B vaccination strategies in Catalonia, Spain. | Pharmacoeconomics | 1995 | https://conductscience.org/library/papers/10155330 | PubMed |
| 10146907 | Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infection. | Pharmacoeconomics | 1994 | https://conductscience.org/library/papers/10146907 | PubMed |
| 8154573 | A cost-benefit analysis of legislation for bicycle safety helmets in Israel. | Am J Public Health | 1994 | https://conductscience.org/library/papers/8154573 | PubMed |
| 8120505 | Cost benefit analysis of Haemophilus influenzae type b vaccination programme in Israel. | J Epidemiol Community Health | 1993 | https://conductscience.org/library/papers/8120505 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1494073
GET https://conductscience.org/api/papers/v1/1494073/references?page=2